Relevant bibliographies by topics / Cervical Cancer

Academic literature on the topic 'Cervical Cancer'

Author: Grafiati
Published: 4 June 2021
Last updated: 6 September 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Contents

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Cervical Cancer.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Cervical Cancer"

1

S Kadam, Sachin, and Tejaswini Kadam. "Endometrial Cancer with Cervical Extension Masquerading as Cervical Cancer." Cancer Research and Cellular Therapeutics 6, no. 3 (May 16, 2022): 01–03. http://dx.doi.org/10.31579/2640-1053/118.

Full text
Abstract:
The incidence and prevalence of endometrial cancer is less as compared to cervical cancer. Worldwide, in 2018, near about 382000 new cases of endometrial cancer were diagnosed and around 90000 women were died from the disease
APA, Harvard, Vancouver, ISO, and other styles
2

Yang, Nan, Esther R. Nijhuis, Haukeline H. Volders, Jasper J. H. Eijsink, Ágnes Lendvai, Bo Zhang, Harry Hollema, Ed Schuuring, G. Bea A. Wisman, and Ate G. J. van der Zeea. "Gene Promoter Methylation Patterns throughout the Process of Cervical Carcinogenesis." Analytical Cellular Pathology 32, no. 1-2 (January 1, 2010): 131–43. http://dx.doi.org/10.1155/2010/306087.

Full text
Abstract:
Objectives: To determine methylation status of nine genes, previously described to be frequently methylated in cervical cancer, in squamous intraepithelial lesions (SIL).Methods: QMSP was performed in normal cervix, low-grade (L)SIL, high-grade (H)SIL, adenocarcinomas and squamous cell cervical cancers, and in corresponding cervical scrapings.Results: Only CCNA1 was never methylated in normal cervices and rarely in LSILs. All other genes showed methylation in normal cervices, with CALCA, SPARC and RAR-β2 at high levels. Methylation frequency of 6 genes (DAPK, APC, TFPI2, SPARC, CCNA1 and CADM1) increased with severity of the underlying cervical lesion. DAPK showed the highest increase in methylation frequency between LSIL and HSIL (10% vs. 40%, p < 0.05), while CCNA1 and TFPI2 were most prominently methylated in cervical cancers compared to HSILs (25% vs. 52%, p < 0.05, 30% vs. 58%, p < 0.05). CADM1 methylation in cervical cancers was related to depth of invasion (p < 0.05) and lymph vascular space involvement (p < 0.01), suggesting a role in invasive potential of cervical cancers. Methylation ratios in scrapings reflected methylation status of the underlying lesions (p < 0.05).Conclusion: Methylation of previously reported cervical cancer specific genes frequently occurs in normal epithelium. However, frequency of methylation increases during cervical carcinogenesis, with CCNA1 and DAPK as the best markers to distinguish normal/LSIL from HSIL/cancer lesions.
APA, Harvard, Vancouver, ISO, and other styles
3

Isakova, Dilnoza, Zebiniso Inakova, Ranokhon Solieva, Matkarimov Bakhtiyorjon, Yorkinoy Farmankulova, and Dilfuzahon Mamarasulova. "Clinical Echocolpocsopy Features Of Cervical Cancer." American Journal of Medical Sciences and Pharmaceutical Research 02, no. 07 (July 31, 2020): 123–29. http://dx.doi.org/10.37547/tajmspr/volume02issue07-16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Singh Randhawa, Amritjot. "Metastatic Breast Cancer to the Uterine Cervix Mimicking Cervical Cancer." Indian Journal of Cancer Education and Research 8, no. 1 (June 1, 2020): 49–52. http://dx.doi.org/10.21088/ijcer.2321.9815.8120.8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

AziziKia, Hani, Hamidreza Didar, Azin Teymourzadeh, Amin Nakhostin-Ansari, Pooya Jafari Doudaran, Bahareh Ferasatifar, Armin Hoveidaei, and Gholamreza Roshandel. "Uterine and Cervical Cancer in Iran: An epidemiologic analysis of the Iranian National Population-Based Cancer Registry." Archives of Iranian Medicine 26, no. 1 (January 1, 2023): 1–7. http://dx.doi.org/10.34172/aim.2023.01.

Full text
Abstract:
Background: Gynecologic cancers, including neoplasms of the cervix and uterine, are the fourth most common malignancies, causing 3.46% of deaths in women aged 15 to 59. Objectives: We aimed to report the Iranian National Population-based Cancer Registry (INPCR) results for Cervical and Uterine cancers in 2017. Methods: The total population of Iran in 2017 was 80881792. INPCR collected data on cervical and uterine cancer incidence from 31 provinces of Iran. In this project, we retrospectively examined all the country’s regions in terms of screening for the existence of these two cancers. The registry data bank in Iran was used. Results: Overall, 3481 new cervical and uterine cancer cases were registered in INPCR, including 842 cases of cervical cancer (with a crude rate of 1.04) and 2639 cases of uterine cancer (with a crude rate of 3.26). The average age-standardized incidence rate (ASR) was 0.99 for cervical cancer and 3.29 for uterine cancer. Out of 3481 new cervical and uterine cancer cases, 2887 were registered with pathological findings and 594 without pathological confirmation. In cervical cancers, the highest rate was related to squamous cell carcinoma, with 486 cases (57.72%). Conclusion: Our results showed that Iran is a low-risk area for the incidence of cervical and uterine cancers. In this study, the highest rate of cervical cancer was related to squamous cell carcinoma, confirming previous reports. However, this rate was lower than previous studies and suggested an increase in other types of cervical cancer in Iran.
APA, Harvard, Vancouver, ISO, and other styles
6

H.K, Dr Sharath Kumar. "Immuno-Histochemical Study of P16INK4A in Cervical Intraepithelial Neoplasia and Cervical Cancer." Journal of Medical Science And clinical Research 05, no. 01 (January 8, 2017): 15415–22. http://dx.doi.org/10.18535/jmscr/v5i1.37.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Der, EM, K. Adu-Bonsaffoh, Y. Tettey, RA Kwame-Aryee, JD Seffah, H. Alidu, and RK Gyasi. "Clinico-pathological characteristics of cervical cancer in Ghanaian women." Journal of Medical and Biomedical Sciences 3, no. 3 (January 13, 2015): 27–32. http://dx.doi.org/10.4314/jmbs.v3i3.5.

Full text
Abstract:
Cervical cancer is a major cause of cancer related mortality in the developing countries, although preventable. The aim of this study was to use a retrospective descriptive study to determine the prevalence and the clinico-pathological characteristics of cervical cancer among genital tract ma-lignancies. This study reviewed all histologically confirmed female genital tract malignancies for cervical cancers from January 2002 to December 2011. The clinico-pathological features of women with cervical cancer were analyzed using SPSS software (version 18). A total of 1011(70.8%) out of 1,427 female genital tract malignancies were cervical cancers. The average prevalence of cervical cancer was 71.0%. The mean age of women with cervical cancer was 57.8(SD=13.8) years. The youngest patient was 22 years. The commonest (76.9%) presentation was bleeding per vaginalm followed by fungating cervical masses (12.4%). Majority (88.9%) of the bleeding were unprovoked and in postmenopausal women (98.8%). The major types of cervical cancers were Squamous cell carcinoma (SCC) (90.1%) and adenocarcinoma (5.8%), both were common in the elderly. The com-mon histological subtypes of cervical cancers in the study were; keratinizing SCC (73.3%), non-keratinizing SCC (14.7%), endometroid adenocarcinoma (4.5%), adenosquamous carcinoma (2.6%) and basaloid SCC (1.4%). This study found high prevalence of cervical cancer among female geni-tal tract cancers in Accra Ghana. The women were relatively older and presented with advanced stage of the disease. SCC was the major histological type of cervical cancer.Keywords: Ghana, cervical cancer, postmenopausal, women, premalignant, genital tract
APA, Harvard, Vancouver, ISO, and other styles
8

Iram, Ayesha. "Cancer Screening Technology and Attitude of Women Towards Cervical Cancer." TEXILA INTERNATIONAL JOURNAL OF ACADEMIC RESEARCH 9, no. 3 (July 30, 2022): 145–67. http://dx.doi.org/10.21522/tijar.2014.09.03.art013.

Full text
Abstract:
Cervical cancer claims over a quarter of a million lives of women annually worldwide. It is believed to be the second most common cancer among women worldwide. Screening is used to detect precancerous changes or early cancers before signs or symptoms of cancer occur. The first case of cervical cancer was founded in the 1970s by Harald Zur Hausen. It is believed to be the second most common cancer among women worldwide. Females becoming sexually active in early age with multiple partners are on high risk. Virtually all cervical cancers are associated with human papilloma viruses (HPV). This study was conducted to understand the levels of knowledge and attitudes of women towards cervical cancer screening in Al Khan Dubai.It assessed the knowledge and attitudes of women about cervical cancer prevention. 70% of the sexually active women really need to go for cancer screening. It shows that 66% of women in al khan are being affected due to lifestyle and it is affecting women’s decision in relation to cervical cancer screening. To improve cervical cancer screening in al khan area, women should be given more information, motivation, awareness, and sensitization, in order to encourage them to go for a cervical cancer screening. Keywords: Cervix, High risk, HPV, Pre-screening methods, Women.
APA, Harvard, Vancouver, ISO, and other styles
9

Dayanand Katke, Rajshree, and Deepti Prasad. "Cervical Cancer Prevention: Current Scenario." Acta Scientific Cancer Biology 4, no. 2 (January 18, 2020): 01–03. http://dx.doi.org/10.31080/ascb.2020.04.cervical-cancer-prevention-current-scenario.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Boisen, Michelle, and Richard Guido. "Emerging Treatment Options for Cervical Dysplasia and Early Cervical Cancer." Clinical Obstetrics & Gynecology 66, no. 3 (July 25, 2023): 500–515. http://dx.doi.org/10.1097/grf.0000000000000790.

Full text
Abstract:
Discussion of treatment strategies for cervical cancer precursors, review of medical therapies and emerging therapeutics for treatment of cervical cancers, and updates on new approaches to treating early-stage cervical cancers.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Cervical Cancer"

1

Ibrahim, Emad Moussa. "CD44 in cervical cancer." Thesis, University of Sheffield, 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.269370.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Thornton, Julia Susan. "Screening for cervical cancer." Thesis, City University London, 1994. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.241442.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Nevin, James. "Pregnancy-associated cervical cancer." Thesis, University of Cape Town, 1991. http://hdl.handle.net/11427/26272.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Ratima, Keri, and n/a. "Cervical cancer in Maori women." University of Otago. Dunedin School of Medicine, 1994. http://adt.otago.ac.nz./public/adt-NZDU20070601.112003.

Full text
Abstract:
This thesis is concerned with cervical cancer amongst New Zealand women, particularly Maori women. Maori women have an alarmingly high incidence of cervical cancer, approximately three times higher than non-Maori women. Maori women experience one of the highest rates of cervical cancer in the world. Chapter one, two and three form the introductory section of the thesis, Section A. Chapter one provides an overview of cervical cancer incidence in the world, followed by a more detailed analysis of the occurrence of cervical cancer in New Zealand and a discussion of the aetiological factors of cervical cancer. Cervical screening is discussed in Chapter two. The ethnic differences in incidence and mortality of cervical cancer between Maori and non-Maori and possible reasons for these differences are studied in Chapter three. Section B consists of the original work undertaken. A pilot study (Chapter four) was conducted to trial the methods for the national study (Chapter five). The national study was a retrospective review of the cervical smear histories of Maori women first diagnosed with invasive cervical cancer over a recent two year period in order to investigate why Maori women have not had their disease detected by screening and treated at the intraepithelial stage. Maori women�s knowledge of and attitudes towards cervical screening were obtained in a survey in Ruatoria (Chapter six). Section C concludes with a chapter (Chapter seven) on the conclusions and recommendations based on the material reviewed and the work undertaken.
APA, Harvard, Vancouver, ISO, and other styles
5

Govorukhina, Natalia I. "Biomarker discovery for cervical cancer." [S.l. : Groningen : s.n. ; University Library of Groningen] [Host], 2007. http://irs.ub.rug.nl/ppn/305362089.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Roeder, Geraldine Elizabeth. "Gene therapy for cervical cancer." Thesis, University of Bristol, 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.268704.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Li, Xing. "Novel brachytherapy techniques for cervical cancer and prostate cancer." Diss., University of Iowa, 2015. https://ir.uiowa.edu/etd/1682.

Full text
Abstract:
Intensity-modulated brachytherapy techniques, compensator-based intensity modulated brachytherapy (CBT) and interstitial rotating shield brachytherapy (I-RSBT), are two novel conceptual radiation therapies for treating cervical and prostate cancer, respectively. Compared to conventional brachytherapy techniques for treating cervical cancer, CBT can potentially improve the dose conformity to the high-risk clinical target volume (CTV) of the cervix in a less invasive approach. I-RSBT can reduce the dose delivered to the prostate organ at risks (OARs) with the same radiation dose delivered to the prostate CTV. In this work, concepts and prototypes for CBT and I-RSBT were introduced and developed. Preliminary dosimetric measurements were performed for CBT and I-RSBT, respectively. A CBT prototype system was constructed and experimentally validated. A prototype cylindrical compensator with eight octants, each with different thicknesses, was designed. Direct metal laser sintering (DMLS) was used to construct CoCr and Ti compensator prototypes, and a 4-D milling technique was used to construct a Ti compensator prototype. Gafchromic EBT2 films, held by an acrylic quality assurance (QA) phantom, were irradiated to approximately 125 cGy with an electronic brachytherapy (eBT) source for both shielded and unshielded cases. The dose at each point on the films were calculated using a TG-43 calculation model that was modified to account for the presence of a compensator prototype by ray-tracing. With I-RSBT, a multi-pass dose delivery mechanism with prototypes was developed. Dosimetric measurements for a Gd-153 radioisotope was performed to demonstrate that using multiple partially shielded Gd-153 sources for I-RSBT is feasible. A treatment planning model was developed for applying I-RSBT clinically. A custom-built, stainless steel encapsulated 150 mCi Gd-153 capsule with an outer length of 12.8 mm, outer diameter of 2.10 mm, active length of 9.98 mm, and active diameter of 1.53 mm was used. A partially shielded catheter was constructed with a 500 micron platinum shield and a 500 micron aluminum emission window, both with 180° azimuthal coverage. An acrylic phantom was constructed to measure the dose distributions from the shielded catheter in the transverse plane using Gafchromic EBT3 films. Film calibration curves were generated from 50, 70, and 100 kVp x-ray beams with NIST-traceable air kerma values to account for energy variation. In conclusion, CBT, which is a non-invasive alternative to supplementary interstitial brachytherapy, is expected to improve dose conformity to bulky cervical tumors relative to conventional intracavitary brachytherapy. However, at the current stage, it would be time-consuming to construct a patient-specific compensator using DMLS, and the quality assurance of the compensator would be difficult. I-RSBT is a promising approach to reducing radiation dose delivered to prostate OARs. The next step in making Gd-153 based I-RSBT feasible in clinic is developing a Gd-153 source that is small enough such that the source, shield, and catheter all fit within a 16 guage needle, which has a 1.65 mm diameter.
APA, Harvard, Vancouver, ISO, and other styles
8

Gunnell, Anthony S. "Risk factors for cervical cancer development /." Stockholm, 2007. http://diss.kib.ki.se/2007/978-91-7357-437-2/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

張德凱 and Dekai Zhang. "Telomerase activation in human cervical cancer." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 1998. http://hub.hku.hk/bib/B31238038.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Ng, Grace. "Genomic investigations of cervical cancer progression." Thesis, University of Cambridge, 2007. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.613036.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Cervical Cancer"

1

Dunleavey, Ruth. Cervical Cancer. New York: John Wiley & Sons, Ltd., 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

de la Garza-Salazar, Jaime G., Flavia Morales-Vásquez, and Abelardo Meneses-Garcia, eds. Cervical Cancer. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-45231-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Keppler, Daniel, and Athena W. Lin, eds. Cervical Cancer. New York, NY: Springer New York, 2015. http://dx.doi.org/10.1007/978-1-4939-2013-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Hirschmann, Kris. Cervical cancer. Detroit: Lucent Books, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Hirschmann, Kris. Cervical cancer. Detroit: Lucent Books/Gale, Cengage Learning, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Hasan, Heather. Cervical cancer. New York: Rosen, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Hirschmann, Kris. Cervical cancer. Detroit: Lucent Books, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Hirschmann, Kris. Cervical cancer. Detroit: Lucent Books/Gale, Cengage Learning, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Royal College of Obstetricians and Gynaecologists., ed. Cervical smears: Preventing cervical cancer. London: RCOG, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Austoker, Joan. Cervical cancer screening. [London]: Cancer Research Campaign, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Cervical Cancer"

1

de la Garza-Salazar, Jaime G., Abelardo Meneses-García, Oscar Arrieta-Rodríguez, José Luis Aguilar-Ponce, and Paula Juarez-Sánchez. "Introduction." In Cervical Cancer, 1–17. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-45231-9_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

González-Enciso, Aarón, Salim Abraham Barquet-Muñoz, and Milagros Pérez-Quintanilla. "Primary Surgical Treatment of Cervical Cancer." In Cervical Cancer, 151–62. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-45231-9_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Montalvo-Esquivel, Gonzalo, Milagros C. Pérez-Quintanilla, Angel Herrera-Gómez, Francisco Javier Alcalá-Prieto, Flavia Morales-Vásquez, and Horacio Noé López Basave. "Surgical Treatment for Advanced or Recurrent Disease in Cervical Cancer." In Cervical Cancer, 163–76. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-45231-9_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Mota-García, Aida, Monika Blake-Cerda, Bonifacio Ramón-Ortega, Roque Alberto Guadarrama-Fleites, and Guadalupe Elizabeth Trejo-Durán. "Radiotherapy in Cervical Cancer." In Cervical Cancer, 177–97. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-45231-9_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Morales-Vásquez, Flavia, Claudia Cano-Blanco, Jaime Alberto Coronel-Martínez, Lucely Cetina-Pérez, Jorge Martínez-Tlahuel, Julio César Velasco-Rodríguez, Horacio N. López-Basave, and Jaime G. de la Garza-Salazar. "Systemic Treatment of Cervical Cancer." In Cervical Cancer, 199–214. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-45231-9_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Marquez-Manriquez, Juan P., Erik Ramos, and Dolores Gallardo-Rincón. "Immuno-Oncology in Cervical Cancer." In Cervical Cancer, 215–23. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-45231-9_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Allende-Pérez, Silvia, Emma Verástegui-Avilés, Dana A. Pérez-Camargo, Georgina Domínguez-Ocadio, and Frank D. Ferris. "Palliative Care in Cervical Cancer Patients." In Cervical Cancer, 225–52. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-45231-9_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Morales-Vásquez, Flavia, Claudia Cano-Blanco, Jaime Alberto Coronel-Martínez, Lucely Cetina-Pérez, Julio César Velasco-Rodríguez, Horacio N. López-Basave, and Jaime G. de la Garza-Salazar. "Special Conditions and Follow-Up in Cervical Cancer." In Cervical Cancer, 253–68. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-45231-9_16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Reynoso-Noverón, Nancy, Adriana Peña-Nieves, Maryori Ortiz Rodríguez, and Alejandro Mohar-Betancourt. "Cervical Cancer Epidemiology." In Cervical Cancer, 19–33. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-45231-9_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Astudillo-de la Vega, H., E. Ruiz-Garcia, C. Lopez-Camarillo, Jaime G. de la Garza-Salazar, A. Meneses-Garcia, and L. Benitez-Bribiesca. "Malignant Transforming Mechanisms of Human Papillomavirus." In Cervical Cancer, 35–56. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-45231-9_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Cervical Cancer"

1

Vemanamandhi, Priyanka. "A Rare mimicker of Cervical Cancer- Cervical Amebiasis." In 10th National Conference of Asia Oceania Research Organisation on Genital Infections and Neoplasia, India. AOGIN 2021, 2021. http://dx.doi.org/10.7869/aogin68.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Srivastava, Astha, Bindiya Gupta, Vikas Lakha, and Shilpa Singh. "Study on cervical cancer screening amongst nurses." In 16th Annual International Conference RGCON. Thieme Medical and Scientific Publishers Private Ltd., 2016. http://dx.doi.org/10.1055/s-0039-1685284.

Full text
Abstract:
Objective: To study the knowledge, attitude and practice of nurses at tertiary centre regarding cervical cancer screening. Material and Methods: Validated questionnaire was circulated amongst staff nurses at tertiary care centre after taking informed consent. Results and Discussion: Cancer of cervix is the most common genital tract malignancy in female and it is ranked second to breast cancer. It has a positive association with HPV infection. Cervical cancer incidence and mortality have declined substantially following introduction of screening programmes. This present study investigated the knowledge, attitude and practice of nurses at GTB Hospital towards cervical cancer risk factors, sign & symptoms and screening as they are important health professionals. In our study, the results showed that 99% of respondents were aware of Pap smear as screening programme and about 60-70% were aware of HPV as positive organism, but most of them never had a Pap smear done before. Majority of them did not know VIA, VILI and colposcopy as screening techniques. Conclusion: It may thus be recommended that institutions should periodically organize seminars and training for health personnel especially the nurses which form a group of professionals that should give health education to women about cervical cancer.
APA, Harvard, Vancouver, ISO, and other styles
3

"Aspirin and Cervical Cancer." In 2016 International Conference on Biological and Environmental Science. Universal Researchers, 2016. http://dx.doi.org/10.17758/ur.u0616230.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Bran, Liliana. "CERVICAL CANCER CLUSTERING IN ARAD AND CERVICAL CANCER SCREENING PROGRAMMES IN ROMANIA." In 5th SGEM International Multidisciplinary Scientific Conferences on SOCIAL SCIENCES and ARTS SGEM2018. STEF92 Technology, 2018. http://dx.doi.org/10.5593/sgemsocial2018h/31/s13.074.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Pâslaru, Ana-Maria, Ana Fulga, Elena Niculet, Laura Florentina Rebegea, Iuliu Fulga, and Anamaria Ciubara. "SUPRACLAVICULAR AND CERVICAL LYMPH NODE METASTASES HAVING CERVICAL CANCER AS STARTING POINT. CASE PRESENTATION." In The European Conference of Psychiatry and Mental Health "Galatia". Archiv Euromedica, 2023. http://dx.doi.org/10.35630/2022/12/psy.ro.10.

Full text
Abstract:
Introduction: Cervical cancer is the fourth most frequently found cancer among women worldwide. Numerous studies have underlined that persistent infection with human papilloma virus is the most important risk factor, two strains of the same virus – 16 and 18 being responsible for approximately 70% of the cases. Cervical cancer rarely metastasizes in the cervical lymph nodes and this indicates a poor prognosis. Literature data reports an incidence for left supraclavicular M1LYm of 0.1-1.5%. Material and Method: We bring attention to the case of a 44-year-old patient from the rural area who was diagnosed in January 2019 with stage IIIB cervical cancer, represented morphologically by a poorly differentiated squamous cell carcinoma. When admitted, the patient presented clinically with vaginal hemorrhage, intense abdominal and pelvic pain, fatigue, a dynamic, significant weight loss. The physiological personal history revealed nine pregnancies, the first one when she was 16. After pretherapeutic evaluation, the multidisciplinary committee decides performing simultaneous radio-chemotherapy with platinum salts. During the second week of treatment clinical examination revealed left cervical and supraclavicular adenopathy, both documented through imaging evaluation. Lymph node biopsy is done and its histopathological aspect, correlated with the immunohistochemistry profile supports the diagnosis of poorly differentiated squamous cell carcinoma lymph node metastasis. The initial treatment scheme is maintained, the patient being discharged with clinical remission of cervical and supraclavicular lymph node metastasis. Conclusions: The peculiarity of the case is determined by the distant metastases in the left cervical and supraclavicular lymph nodes, a rare finding during treatment, which was associated with a poor prognosis; in this case treatment was done for palliative purposes. Rapid diagnosis is the main factor that conditions the therapeutic results and chances for healing.
APA, Harvard, Vancouver, ISO, and other styles
6

Amengual, J., A. Torrent, AM Quintero Duarte, and M. Ruiz. "385 Undiagnosed invasive cervical cancer." In ESGO 2021 Congress. BMJ Publishing Group Ltd, 2021. http://dx.doi.org/10.1136/ijgc-2021-esgo.27.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Jiamset, Ingporn, Kulisara Nanthamongkolkul, and Rakchai Buhachat. "Ovarian transposition and cervical cancer." In The 7th Biennial Meeting of Asian Society of Gynecologic Oncology. Korea: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology, 2021. http://dx.doi.org/10.3802/jgo.2021.32.s1.c27.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Herman, B. "APPLICATIONS OF LASER OPTICAL MICROSCOPIC TECHNIQUES IN DECIPHERING DISEASE SPECIFIC MECHANISMS AND DIAGNOSIS." In Biomedical Optical Spectroscopy and Diagnostics. Washington, D.C.: Optica Publishing Group, 2006. http://dx.doi.org/10.1364/bosd.1996.ft5.

Full text
Abstract:
Accumulating evidence strongly associates human papillomavirus infection with the development of cervical cancers. However, it has also become increasingly clear that HPV infections of the cervix span a wide clinical spectrum from benign lesions to precancerous lesions, with only a minority of infections resulting in invasive cancers, although the reasons for this are not clear. Longitudinal epidemiologic studies using cytologic methods to detect HPV infection have shown that the majority of women infected with HPV will regress spontaneously. In addition, age-stratified data for rates of HPV positivity from cross-sectional studies also suggest that many women clear the infection spontaneously. These results support the concept that many women may be only transiently infected with HPV during their life span and only in women with persistent HPV infection does cervical cancer progress. In addition to persistence of HPV infection, recent epidemiological studies indicate that the amount of high-risk HPV (viral load or HPV gene copy number) in cervicovaginal epithelial cells may be a risk factor for cervical cancer. Thus, a technique which could detect, genotype and quantitate HPV in smears of cervicovaginal epithelial cells would be of major import in assessment of patient clinical status as well as in epidemiological studies relating HPV infection to cervical cancer.
APA, Harvard, Vancouver, ISO, and other styles
9

Vaidya, Sarayoo Ravishankar. "112 Villages against cervical cancer: improving India’s cervical cancer burden by empowering ASHA workers." In Leaders in Healthcare Conference, 17–20 November 2020. BMJ Publishing Group Ltd, 2020. http://dx.doi.org/10.1136/leader-2020-fmlm.112.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Banila, C., B. Nedjai, C. Reuter, K. Cuschieri, G. Clifford, and A. Lorincz. "77 Cervical pre-cancer vs invasive cancer: molecular differentiation with potential of improving cervical cancer screening worldwide." In IGCS Annual 2019 Meeting Abstracts. BMJ Publishing Group Ltd, 2019. http://dx.doi.org/10.1136/ijgc-2019-igcs.77.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Cervical Cancer"

1

Wilbur, David C., Barbara A. Crothers, John H. Eichhorn, Min S. Ro, and Jeffrey A. Gelfand. Internet-Based Cervical Cancer Screening Program. Fort Belvoir, VA: Defense Technical Information Center, May 2008. http://dx.doi.org/10.21236/ada486866.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Ciapponi, Agustín. What is the effectiveness of interventions targeted at women to improve the uptake of cervical cancer screening? SUPPORT, 2016. http://dx.doi.org/10.30846/1611112.

Full text
Abstract:
World-wide, cervical cancer is the second most common cancer in women and more than 85% of women dying from cervical cancer live in the developing world. Increasing the uptake of screening, alongside increasing informed choice, is key to controlling this disease through prevention and early detection. Methods of encouraging women to undergo cervical screening include invitations to screening; reminders to attend screening; education to increase knowledge of screening programmes or of cervical cancer; message framing (positive or negative messages about screening); counselling regarding barriers to screening; risk factor assessment of individuals; procedures, such as making the screening process easier; and economic interventions, such as incentives to attend screening.
APA, Harvard, Vancouver, ISO, and other styles
3

Hoeijmakers, Yvonne M. Cervical biopsy after chemoradiation for locally advanced cervical cancer to identify residual disease: a retrospective cohort study. Science Repository OÜ, March 2019. http://dx.doi.org/10.31487/j.jso.2019.01.001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Yelena, Gorina, and Elgaddal Nazik. Patterns of Mammography, Pap Smear, and Colorectal Cancer Screening Services Among Women Aged 45 and Over. National Center for Health Statistics, June 2021. http://dx.doi.org/10.15620/cdc:105533.

Full text
Abstract:
This study examines and compares sociodemographic, health status, and health behavior patterns of screening for breast cancer, cervical cancer, and colorectal cancer among women aged 45 and over in the United States.
APA, Harvard, Vancouver, ISO, and other styles
5

Zou, Yihua, Fangqin Tong, Meng Guan, Chun Bi, and Xia Wang. Efficacy and safety of Anti-angiogenesis combined with chemoradiotherapy in the treatment of locally advanced cervical cancer: A Meta-Analysis of Randomized Controlled Trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, July 2022. http://dx.doi.org/10.37766/inplasy2022.7.0077.

Full text
Abstract:
Review question / Objective: To Systematicly evaluate of the clinical efficacy and safety of the combination of anti-angiogenesis and simultaneous radiotherapy in the treatment of cervical cancer. Condition being studied: Locally advanced cervical cancer. We searched databases including PubMed, Cochrane Library, Embase, Web of Science CNKI, Wanfang, VIP and CBM, and the International Clinical Trial Registry Platform (ICTRP) and the Chinese Clinical Registry(ChiCTR) to collect the clinical studies about the randomized controlled trial (RCTS) of anti-angiogenic drugs (mainly Endu, apatinib and bevacizumab) combined with chemoradiotherapy in the treatment of cervical cancer. The time limit is from the establishment of the database to April 2022. RevMan 5.4 software was used to analyze the short-term efficacy and the incidence of adverse reactions.
APA, Harvard, Vancouver, ISO, and other styles
6

Guo, Ying, Linlin Ma, and Qiwei Li. Laparoscopic nerve sparing radical hysterectomy for the treatment of cervical cancer. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, September 2021. http://dx.doi.org/10.37766/inplasy2021.9.0047.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Li, Yue, Zhen Gong, Longbiao Zhu, Jing Han, and Hanzi Xu. Circulating MicroRNAs as Potential Diagnostic Biomarkers for Cervical Intraepithelial Neoplasia and early Cervical Cancer : A Systematic Review and Meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, April 2023. http://dx.doi.org/10.37766/inplasy2023.4.0053.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Chen, Xuefeng, Haoyu Wang, and Yu Wang. The diagnostic value of liquid biopsy for cervical cancer: A meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, July 2022. http://dx.doi.org/10.37766/inplasy2022.7.0122.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Huang, Kecheng, Yindi Bao, and Hailong Huang. Acupuncture for chemotherapy-induced myelosuppression of cervical cancer: A protocol for systematic review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, March 2022. http://dx.doi.org/10.37766/inplasy2022.3.0101.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Guo, Yaru, Mingna Xu, and Miao Fang. Recombinant human adenovirus-p53 therapy for the treatment of cervical cancer : a meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, May 2021. http://dx.doi.org/10.37766/inplasy2021.5.0058.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Cervical Cancer' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography